Skip to main content

Researchers receive up to $10.7 million to study chlamydia vaccine

May 30, 2019

  Chlamydia is the most prevalent bacterial sexually transmitted infection (STI) in the world. There is no vaccine to prevent infection. However, researchers from the University of North Carolina at Chapel Hill, in partnership with colleagues at other sites in the U.S., Europe and Australia, will receive up to $10.7 million over five years from … Read more